Clinical Trial Update: Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone [Phase 3]

View source ↗

Summary

This Phase 3 trial compared the efficacy and safety of CWP-0403 to sitagliptin in adults with type 2 diabetes mellitus inadequately controlled on metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CWP-0403
• Sitagliptin (sitagliptin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED